Erasme hospital
Brussels, 1070, Belgium
Location status: Recruiting
Location contact
Elza Abdessater, MD
SUB_INVESTIGATOR
Philippe van de Borne, MD, PhD
CONTACT
2 555 39 60 ext. +32
Philippe van de Borne, MD, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06286358
Kinocardiography (KCG) is a portable measurement technique developed to estimate cardiac mechanical performance by studying the vibrations produced by myocardial contraction during each heartbeat and transmitted to the body surface.
The goal of this observational study is to learn about kinocardiography in patients with aortic valve disease (AVD) or thoracic aortic aneurysm (TAA). The investigators believe that this technology will enable to diagnose aortic valve disease and aortic aneurysm.
In patients with AVD of different severities or TAA, the investigators will collect informations from echocardiography and/or cardiac magnetic resonance imaging, KCG recordings, phonocardiography (PCG) recordings, and video recordings. Researchers will also compare subjects without any AVD nor TAA to better understand these effects on KCG, PCG and video signal.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Brussels, 1070, Belgium
Location status: Recruiting
Elza Abdessater, MD
SUB_INVESTIGATOR
Philippe van de Borne, MD, PhD
CONTACT
2 555 39 60 ext. +32
Philippe van de Borne, MD, PhD
PRINCIPAL_INVESTIGATOR
Aortic valve disease (AVD) is a common but under-diagnosed disease which can cause various cardiovascular complications. AVD, including aortic stenosis and aortic regurgitation, can be associated with dilatation of the ascending thoracic aorta as a result of hemodynamic mechanisms and genetic predisposition. In the assessment of an AVD, it is important to consider if it is associated with a thoracic aortic aneurysm (TAA), and vice versa.
The prevalence of TAA in the general population is difficult to assess because most patients are asymptomatic, and their lethal complications (rupture and dissections) are often misdiagnosed as myocardial infarctions. The insidious evolution of aortic pathology motivates physicians to make the diagnosis as early as possible before the appearance of irreversible lesions causing significant morbidity and mortality. Traditional semiology can be useful for AVD screening (auscultation of a murmur, or observation of some visible semiological signs). However, it relies on the proficiency of care providers and may not allow a timely diagnosis of less severe forms of the disease. Moreover, imaging techniques used in current clinical practice are not appropriate for the organization of large-scale screening in asymptomatic patients. In addition, none of these techniques are accessible for the people living far away from a healthcare institution.
Kinocardiography (KCG) is a portable measurement technique developed to estimate cardiac mechanical performance by studying the vibrations produced by myocardial contraction during each heartbeat and transmitted to the body surface. Signals are recorded thanks to a sensor placed on the sternum, another sensor placed on the lower back and electrocardiogram electrodes.
Smartphones are equipped with accelerometers and gyroscope, and may allow anyone to measure their own cardiac mechanical function similarly to KCG.
Phonocardiography (PCG) enables the detailed recording and analysis of heart sounds produced by the blood flow during the opening and closing of heart valves thanks to a microphone. It allows the extraction of heart sound information that reveals valvular diseases, such as the timing of heart valve closure, the frequency content of heart sounds, and the presence of diastolic or systolic murmurs.
Video image processing by Remote photoplethysmography (RPPG) or by Eulerian video magnification (EVM) allow the analysis of color changes and movements, invisible to the naked eye.
The primary objective of this prospective observational study is to better understand and assess KCG signals modifications due to aortic valve disease (AVD) and/or thoracic aortic aneurysm (TAA). It will be possible thanks to imaging techniques such as 4D flow MRI, and thanks to a comparison with PCG. The secondary objective of our study is to evaluate if a smartphone can be used for the diagnostic and characterization of AVD, using KCG, PCG or video image processing.
The possible participants will be identified, according to inclusion/exclusion criteria. Informed consent will be given to the patients. Immediately after the echocardiography and/or the cardiac MRI, the investigators will record KCG and PCG data, and then perform similar measurements using a smartphone placed on the torso. These measurements are followed by two short video recordings of 30 seconds, simultaneously to a KCG recording. For patients undergoing aortic valve replacement or thoracic aortic aneurysm surgery, the investigators will also perform the KCG measurements post-operatively, immediately after de post-operative cardiac MRI and/or echocardiography.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Technology Measuring Cardiac Mechanical Activity Via Accelerometers and Gyroscopes
Time frame: 12 months
Correlation between KCG parameters and imaging parameters (echocardiography, 4D flow MRI)
Time frame: 18 months
Correlation between KCG parameters, phonocardiography, semiological signs and video signals
Time frame: 18 months
With a dedicated device and with a smartphone
Contact information is provided by the study sponsor or research team.
Elza Abdessater, MD
CONTACT
2 555 32 75 ext. +32
Philippe van de Borne, MD, PhD
CONTACT
2 555 39 60 ext. +32
Université Libre de Bruxelles
Other
Impact of Aortic Valve Disease and Thoracic Aortic Aneurysm on Kinocardiographic Signals
Acronym: ARTIK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04149600
Aneurysm, Aortic Aneurysm
Boston, Massachusetts, United States
View Trial DetailsNCT07267117
Aortic Valve Disease, Aortic Valve Insufficiency
Fuzhou, Fujian, China
View Trial DetailsNCT06235385
Aortic Valve Disease, Aortic Valve Insufficiency
Paris, Île-de-France Region, France
View Trial DetailsNCT06069232
Aortic Valve Disease, Aortic Valve Insufficiency
Guangzhou, Guangdong, China
View Trial Details